ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Low‐density‐lipoprotein apheresis‐mediated endothelial activation therapy to severe‐peripheral artery disease study: Rationale and study design
Therapeutic Apheresis and Dialysis
◽
10.1111/1744-9987.13546
◽
2020
◽
Vol 24
(5)
◽
pp. 524-529
Author(s):
Eiko Ueda
◽
Yoshiyuki Toya
◽
Hiromichi Wakui
◽
Yuki Kawai
◽
Kengo Azushima
◽
...
Keyword(s):
Peripheral Artery Disease
◽
Study Design
◽
Low Density Lipoprotein
◽
Density Lipoprotein
◽
Endothelial Activation
◽
Low Density
◽
Peripheral Artery
◽
Artery Disease
◽
Activation Therapy
◽
Disease Study
Download Full-text
Related Documents
Cited By
References
Faculty Opinions recommendation of Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.732115059.793542827
◽
2018
◽
Author(s):
Wilbert Aronow
Keyword(s):
Peripheral Artery Disease
◽
Outcomes Research
◽
Low Density Lipoprotein
◽
Density Lipoprotein
◽
Elevated Risk
◽
Low Density
◽
Low Density Lipoprotein Cholesterol
◽
Peripheral Artery
◽
Artery Disease
◽
Pcsk9 Inhibition
Download Full-text
P1635Impact of serum low-density lipoprotein cholesterol level after endovascular therapy for symptomatic peripheral artery disease
European Heart Journal
◽
10.1093/eurheartj/ehy565.p1635
◽
2018
◽
Vol 39
(suppl_1)
◽
Author(s):
Y Tomoi
◽
K Yamaji
◽
Y Soga
◽
S Hiramori
◽
K Ando
Keyword(s):
Cholesterol Level
◽
Peripheral Artery Disease
◽
Endovascular Therapy
◽
Low Density Lipoprotein
◽
Density Lipoprotein
◽
Lipoprotein Cholesterol
◽
Low Density
◽
Low Density Lipoprotein Cholesterol
◽
Peripheral Artery
◽
Artery Disease
Download Full-text
Impact of different statins on low-density lipoprotein cholesterol levels in patients with peripheral artery disease
Atherosclerosis
◽
10.1016/j.atherosclerosis.2021.06.886
◽
2021
◽
Vol 331
◽
pp. e288
Author(s):
K. Gebauer
◽
N. Malyar
Keyword(s):
Peripheral Artery Disease
◽
Low Density Lipoprotein
◽
Density Lipoprotein
◽
Lipoprotein Cholesterol
◽
Low Density
◽
Low Density Lipoprotein Cholesterol
◽
Peripheral Artery
◽
Cholesterol Levels
◽
Artery Disease
Download Full-text
Letter by Calabrò et al Regarding Article, “Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)”
Circulation
◽
10.1161/circulationaha.117.033137
◽
2018
◽
Vol 138
(2)
◽
pp. 218-219
Author(s):
Paolo Calabrò
◽
Felice Gragnano
◽
Arturo Cesaro
Keyword(s):
Peripheral Artery Disease
◽
Outcomes Research
◽
Low Density Lipoprotein
◽
Density Lipoprotein
◽
Elevated Risk
◽
Low Density
◽
Low Density Lipoprotein Cholesterol
◽
Peripheral Artery
◽
Artery Disease
◽
Pcsk9 Inhibition
Download Full-text
Response by Bonaca and Sabatine to Letters Regarding Article, “Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)”
Circulation
◽
10.1161/circulationaha.118.034864
◽
2018
◽
Vol 138
(2)
◽
pp. 222-223
◽
Cited By ~ 1
Author(s):
Marc P. Bonaca
◽
Marc S. Sabatine
Keyword(s):
Peripheral Artery Disease
◽
Outcomes Research
◽
Low Density Lipoprotein
◽
Density Lipoprotein
◽
Elevated Risk
◽
Low Density
◽
Low Density Lipoprotein Cholesterol
◽
Peripheral Artery
◽
Artery Disease
◽
Pcsk9 Inhibition
Download Full-text
Letter by Alkhalil Regarding Article, “Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)”
Circulation
◽
10.1161/circulationaha.117.033207
◽
2018
◽
Vol 138
(2)
◽
pp. 220-221
Author(s):
Mohammad Alkhalil
Keyword(s):
Peripheral Artery Disease
◽
Outcomes Research
◽
Low Density Lipoprotein
◽
Density Lipoprotein
◽
Elevated Risk
◽
Low Density
◽
Low Density Lipoprotein Cholesterol
◽
Peripheral Artery
◽
Artery Disease
◽
Pcsk9 Inhibition
Download Full-text
Small Dense Low Density Lipoprotein Particles Are Associated with Poor Outcome after Angioplasty in Peripheral Artery Disease
PLoS ONE
◽
10.1371/journal.pone.0108813
◽
2014
◽
Vol 9
(9)
◽
pp. e108813
◽
Cited By ~ 4
Author(s):
Vincenzo Jacomella
◽
Philipp A. Gerber
◽
Kathrin Mosimann
◽
Marc Husmann
◽
Christoph Thalhammer
◽
...
Keyword(s):
Peripheral Artery Disease
◽
Low Density Lipoprotein
◽
Density Lipoprotein
◽
Low Density
◽
Peripheral Artery
◽
Lipoprotein Particles
◽
Poor Outcome
◽
Artery Disease
Download Full-text
Therapeutic Potential of Low-Density Lipoprotein Apheresis in the Management of Peripheral Artery Disease in Patients With Chronic Kidney Disease
Therapeutic Apheresis and Dialysis
◽
10.1111/j.1744-9987.2012.01149.x
◽
2012
◽
Vol 17
(2)
◽
pp. 185-192
◽
Cited By ~ 12
Author(s):
Kouichi Tamura
◽
Yuko Tsurumi-Ikeya
◽
Hiromichi Wakui
◽
Akinobu Maeda
◽
Masato Ohsawa
◽
...
Keyword(s):
Chronic Kidney Disease
◽
Kidney Disease
◽
Peripheral Artery Disease
◽
Therapeutic Potential
◽
Low Density Lipoprotein
◽
Density Lipoprotein
◽
Low Density
◽
Peripheral Artery
◽
Lipoprotein Apheresis
◽
Artery Disease
Download Full-text
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease
Circulation
◽
10.1161/circulationaha.117.032235
◽
2018
◽
Vol 137
(4)
◽
pp. 338-350
◽
Cited By ~ 253
Author(s):
Marc P. Bonaca
◽
Patrice Nault
◽
Robert P. Giugliano
◽
Anthony C. Keech
◽
Armando Lira Pineda
◽
...
Keyword(s):
Peripheral Artery Disease
◽
Low Density Lipoprotein
◽
Density Lipoprotein
◽
Lipoprotein Cholesterol
◽
Low Density
◽
Low Density Lipoprotein Cholesterol
◽
Peripheral Artery
◽
Cholesterol Lowering
◽
Artery Disease
Download Full-text
The cost-effectiveness of intensive low-density lipoprotein cholesterol lowering in people with peripheral artery disease
Journal of Vascular Surgery
◽
10.1016/j.jvs.2020.08.129
◽
2020
◽
Author(s):
Domenico R. Nastasi
◽
Joseph V. Moxon
◽
Richard Norman
◽
Alexandra F. Trollope
◽
Sophie Rowbotham
◽
...
Keyword(s):
Cost Effectiveness
◽
Peripheral Artery Disease
◽
Low Density Lipoprotein
◽
Density Lipoprotein
◽
Lipoprotein Cholesterol
◽
Low Density
◽
Low Density Lipoprotein Cholesterol
◽
Peripheral Artery
◽
Artery Disease
◽
The Cost
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close